Joanna Wiensch
Stock Analyst at Citigroup
(2.55)
# 2,341
Out of 5,008 analysts
30
Total ratings
71.43%
Success rate
7.87%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $217 → $185 | $192.53 | -3.91% | 7 | May 22, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $133.02 | -4.53% | 8 | Aug 22, 2024 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $66.03 | +36.68% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $69.02 | +15.18% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Technologies | Initiates: Buy | $120 | $177.62 | -32.44% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $249.04 | -19.69% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $84.09 | -52.43% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $99.06 | +69.59% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $75.37 | -16.41% | 1 | Mar 5, 2020 | |
| SYK Stryker | Initiates: Buy | $235 | $369.24 | -36.36% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $313.45 | -29.81% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $76.72 | +9.49% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $22.90 | +310.48% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $188.89 | -13.71% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $98.33 | +26.11% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
May 22, 2025
Downgrades: Neutral
Price Target: $217 → $185
Current: $192.53
Upside: -3.91%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $133.02
Upside: -4.53%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $66.03
Upside: +36.68%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $69.02
Upside: +15.18%
iRhythm Technologies
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $177.62
Upside: -32.44%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $249.04
Upside: -19.69%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $84.09
Upside: -52.43%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $99.06
Upside: +69.59%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $75.37
Upside: -16.41%
Stryker
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $369.24
Upside: -36.36%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $313.45
Upside: -29.81%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $76.72
Upside: +9.49%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $22.90
Upside: +310.48%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $188.89
Upside: -13.71%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $98.33
Upside: +26.11%